In Other News

• Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial

• Temporal Immune Profiling Reveals How Sepsis States Change Over Time

• Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19

• Blood Metabolite Signature Predicts ALS Progression and Points to Treatment Strategy

• Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins

• Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19

• Blood Metabolite Signature Predicts ALS Progression and Points to Treatment Strategy

• New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

• New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

• Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

• Single Genetic Analysis Identifies Causes of Premature Ovarian Insufficiency

• Gut “Memory” May Explain Why IBD Flares Return

• New Automation Platform Standardizes DNA and RNA Extraction Across Clinical Workflows

• Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins

• Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

• New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

• Multiprotein Plasma Panel Identifies Remission in Vasculitis

• AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

• Companion Diagnostics Expand HER2 Testing in Metastatic Gastroesophageal Cancer

• Companion Diagnostics Expand HER2 Testing in Metastatic Gastroesophageal Cancer

• Rapid Urine Biomarker Panel Supports Better Kidney Transplant Decisions

• Global Urinalysis Market Gowth Driven by Demand for Automated and POC Testing

• New Liquid Biopsy Approach Shows Promise for Detecting Breast Cancer Recurrence